These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9700889)
41. [Effectiveness of bacterial preparations bifidumbacterin and bificol in the treatment of chronic enterocolitis complicated by dysbacteriosis]. Krums LM; Zhukovskaia NA; Semenova LP; Goncharova GI; Pospelova VV Ter Arkh; 1975; 47(8):86-9. PubMed ID: 1188656 [No Abstract] [Full Text] [Related]
42. [The characteristics of the microbiocenosis and local immunity of the intestines in newborns with an intrauterine infection]. Zakharova NI; Partsalis EM; Likhacheva TM; Soiunova OIu; Redzhepov EM; Karlyeva MF; Monakova OA Akush Ginekol (Mosk); 1993; (4):51-3. PubMed ID: 8250122 [No Abstract] [Full Text] [Related]
43. Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity. Sallenave JM Am J Respir Cell Mol Biol; 2010 Jun; 42(6):635-43. PubMed ID: 20395631 [TBL] [Abstract][Full Text] [Related]
44. Children dying from pneumonia: are we doing enough? Gie RP; Enarson PM Int J Tuberc Lung Dis; 2006 Aug; 10(8):828. PubMed ID: 16898364 [No Abstract] [Full Text] [Related]
45. [Modern aspects of the normal state and pathology of intestinal microflora (a review of the literature)]. Lebedeva MN; Goncharova GI; Liz'ko NN Zh Mikrobiol Epidemiol Immunobiol; 1974 Sep; (9):36-41. PubMed ID: 4613083 [No Abstract] [Full Text] [Related]
46. [Effects of early administration of bifidobacterin on the composition of the intestinal microflora of newborn infants in an intensive care unit]. Kudinova TI; Maĭorova VN Akush Ginekol (Mosk); 1986 Dec; (12):59-61. PubMed ID: 2950801 [No Abstract] [Full Text] [Related]
47. Managing community-acquired pneumonia. Factors to consider in outpatient care. Farber MO Postgrad Med; 1999 Apr; 105(4):106-14. PubMed ID: 10223090 [TBL] [Abstract][Full Text] [Related]
48. [Intestinal dysbacteriosis in yersiniosis patients and the possibility of its correction with biopreparations]. Kuznetsov VF; Iushchuk ND; Iurko LP; Nabokova NIu Ter Arkh; 1994; 66(11):17-8. PubMed ID: 7900004 [TBL] [Abstract][Full Text] [Related]
49. [Etiology of community-acquired bronchitis and pneumonia in young children and the choice of antibacterial therapy]. Samsygina GA; Okhlopkova KA; Suslova OV Antibiot Khimioter; 2000; 45(11):29-30. PubMed ID: 11210300 [No Abstract] [Full Text] [Related]
50. [The dysbacteriosis of extreme states]. Liz'ko NN Antibiot Med Biotekhnol; 1987 Mar; 32(3):184-6. PubMed ID: 3579245 [TBL] [Abstract][Full Text] [Related]
51. [Use of enterosorbent in the treatment of intestinal dysbiosis]. Shcherbakov PL Eksp Klin Gastroenterol; 2009; (3):88-92. PubMed ID: 19928005 [TBL] [Abstract][Full Text] [Related]
52. Report of increased number of children with parapneumonic empyema as a complication of bacterial pneumonia in West Virginia in 2005. Moffett K; Tantoco AM W V Med J; 2011; 107(2):14-9. PubMed ID: 21476472 [No Abstract] [Full Text] [Related]
53. [Microbial ecology of the intestines in health and in pathology]. Goncharova GI; Dorofeĭchuk VG; Smolianskaia AZ; Sokolova KIa Antibiot Khimioter; 1989 Jun; 34(6):462-6. PubMed ID: 2802880 [TBL] [Abstract][Full Text] [Related]
55. [Use of bifidumbacterin and complex therapy of prolonged intestinal dysfunction in young children]. Aleksandrova AM; Zatsepin IuK; Goncharova GI Vopr Okhr Materin Det; 1970 Nov; 15(11):40-3. PubMed ID: 5532748 [No Abstract] [Full Text] [Related]
56. A bacteriological study in hospitalized children with pneumonia. Bahl R; Mishra S; Sharma D; Singhal A; Kumari S Ann Trop Paediatr; 1995 Jun; 15(2):173-7. PubMed ID: 7677421 [TBL] [Abstract][Full Text] [Related]
57. Antibiotic and systemic therapies for pneumonia in human immunodeficiency virus (HIV)-infected and HIV-exposed children. Punpanich W; Groome M; Muhe L; Qazi SA; Madhi SA J Infect Dev Ctries; 2012 Feb; 6(2):109-19. PubMed ID: 22337838 [TBL] [Abstract][Full Text] [Related]
58. [Levofloxacin in the treatment of respiratory infections]. Iakovlev SV; Iakovlev VP Antibiot Khimioter; 2002; 47(8):32-42. PubMed ID: 12515095 [No Abstract] [Full Text] [Related]
59. [Experience in the use of bifidumbacterin in children with prolonged intestinal diseases]. Zatsepin IuK; D'iakova EI; Goncharova GI; Liannaia AM; Kozlova EP; Aleksandrova AM; Kozhevitskaia OB Pediatriia; 1970 May; 49(5):62-4. PubMed ID: 5447911 [No Abstract] [Full Text] [Related]
60. [Use of loading doses of bifidumbacterin forte for treatment of patients with acute enteric infections]. Korviakova EP Zh Mikrobiol Epidemiol Immunobiol; 2000; (6):58-61. PubMed ID: 11210639 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]